reference/3381960

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3381960

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
issn	1758-9193
issueIdentifier	1
pageRange	160-
publicationName	Alzheimer's Research & Therapy
startingPage	160
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cdfbe8dabae71852c2fec3e5f76c7740 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_18db4a0e26a363ffe38165cf5dd12af5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_762e8a7a885af3b7a0c4bb4d5789b953 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8baeae928814f2d46a1d1f998973f2df http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e57a2df28cd3d691c9ebea9a73b49d7b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_748fa36d76ef4195e533fa364f1baca5
bibliographicCitation	De Kort AM, Kuiperij HB, Alcolea D, Kersten I, Versleijen AAM, Greenberg SM, Stoops E, Schreuder FHBM, Klijn CJM, Lleó A, Claassen JAHR, Verbeek MM. Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy. Alzheimer's Research & Therapy. 2021 Nov 16;13(1):189. doi: 10.1186/s13195-021-00929-x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea0c3f894292783a4d653b52f965bc96 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7a9fcce4d1aca1d97b924f8bc5f0b0a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e19809ede75aa9039dd1c171924edec0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99a8eae17b946b60e9f55f5ee933e461 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0dbc69420ba2164d801f1c27e700504 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e329c26c4ebd822514e8501158a5b293 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23c08869844aec661d292514ffe4cd9d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd24470cc651002164bc19ed83cee10a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db9934dbea670e95ca00c6444b5f7019 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65ab863c69b72e697261abbcca4374a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2337c94af8c0f4f3d776a92605ec0fde http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae6d1e8c34aba73881dc30dffe5a28e8
date	2021-11-16^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/34560885 https://pubmed.ncbi.nlm.nih.gov/PMC8464117 https://doi.org/10.1186/s13195-021-00929-x https://doi.org/10.1186/s13195-021-00899-0 https://pubmed.ncbi.nlm.nih.gov/34784952
isPartOf	https://portal.issn.org/resource/ISSN/1758-9193 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/36104
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://scigraph.springernature.com/ https://www.crossref.org/
title	Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer’s disease, but not in cerebral amyloid angiopathy
discusses	http://id.nlm.nih.gov/mesh/M0009354 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M0026339 http://id.nlm.nih.gov/mesh/M0024786 http://id.nlm.nih.gov/mesh/M0445025 http://id.nlm.nih.gov/mesh/M0014655
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000544Q000150 http://id.nlm.nih.gov/mesh/D016657Q000150
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016229 http://id.nlm.nih.gov/mesh/D009414 http://id.nlm.nih.gov/mesh/D015415 http://id.nlm.nih.gov/mesh/D005956 http://id.nlm.nih.gov/mesh/D017346
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10435 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9904 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8c5d1a612ef2f7a7fd315f80ce99b915 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10759784 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11262 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d6e75560e5588a5e8000b5ba5e20faae http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6860

Showing number of triples: 1 to 61 of 61.